1. Home
  2. CYTK vs ONB Comparison

CYTK vs ONB Comparison

Compare CYTK & ONB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.83

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Logo Old National Bancorp

ONB

Old National Bancorp

HOLD

Current Price

$24.92

Market Cap

9.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ONB
Founded
1997
1834
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
9.5B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
CYTK
ONB
Price
$60.83
$24.92
Analyst Decision
Buy
Buy
Analyst Count
22
15
Target Price
★ $109.90
$29.60
AVG Volume (30 Days)
1.8M
★ 4.1M
Earning Date
11-04-2026
10-21-2026
Dividend Yield
N/A
★ 2.33%
EPS Growth
N/A
★ 6.55
EPS
N/A
★ 0.59
Revenue
$13,368,000.00
★ $125,616,000.00
Revenue This Year
$70.12
$13.95
Revenue Next Year
$183.63
$5.33
P/E Ratio
★ N/A
$42.31
Revenue Growth
N/A
★ 6.07
52 Week Low
$54.30
$19.39
52 Week High
$88.31
$27.36

Technical Indicators

Market Signals
Indicator
CYTK
ONB
Relative Strength Index (RSI) 24.31 43.08
Support Level $59.05 $24.04
Resistance Level $67.04 $25.52
Average True Range (ATR) 2.06 0.48
MACD -0.37 -0.01
Stochastic Oscillator 3.95 49.44

Price Performance

Historical Comparison
CYTK
ONB

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ONB Old National Bancorp

Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.

Share on Social Networks: